EMEA-001012-PIP01-10-M01

Key facts

Active substance
Chemically modified extract of trees pollen from birch and alder
Therapeutic area
Pneumology-allergology
Decision number
P/0086/2019
PIP number
EMEA-001012-PIP01-10-M01
Pharmaceutical form(s)
Sublingual tablets
Condition(s) / indication(s)
Treatment of allergic rhinitis / rhino-conjunctivitis
Route(s) of administration
Sublingual use
Contact for public enquiries
Granzer Regulatory Consulting & Services

Tel.: +39 0258198222
E-mail: regulatory@lofarma.it

Decision type
RPM: decision refers to a refusal on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating